NY AG Secures $720M from Eight Opioid Drug Companies

New York – In a groundbreaking move to tackle the deadly grip of the opioid crisis, New York Attorney General Letitia James has secured an astonishing $720 million from eight pharmaceutical giants. The funds are allocated to combat addiction, treatment, and prevention efforts in New York and across the nation.

Attorney General James stated, “For years, drug companies prioritized profits over human lives, leaving countless New Yorkers trapped in a cycle of addiction”. She vowed to continue holding these corporations accountable.

The eight companies involved are Mylan (now part of Viatris), Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, and Zydus. Each company will pay a specific amount over varying time frames, with payments set to begin in 2026.

Additionally, the companies are required to cease promoting opioids and certain high-dose medications, implement monitoring systems for suspicious orders, and provide treatment medications or cash in lieu of these products.

This settlement marks another significant victory for Attorney General James. To date, her efforts have resulted in over $3 billion for New York’s opioid abatement, treatment, and prevention programs. This includes settlements with Purdue, Teva Pharmaceuticals, Johnson & Johnson, and others.

The negotiation team was led by Special Counsel Monica Hanna and Assistant Attorney General Matthew Conrad, supported by Gautam Sisodia and Kenneth Morales. The multistate coalition also includes attorneys general from California, Colorado, Illinois, North Carolina, Oregon, Tennessee, Utah, and Virginia.